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Abstract : Depression often first develops during adolescence, with its rate sharply increasing after puberty and 
often running a chronic, recurring course thereafter. The development of depression is associated with diffi-
culties in the lives of adolescents and their families, reduced academic achievement, suicide, and increased so-
cio-economic disadvantage in adulthood. Earlier and more effective interventions for depression in adolescents 
are required. This review describes the updated etiology and clinical features of adolescent depression, and fo-
cuses on appropriate therapeutic strategies to adopt in clinical practice. J. Med. Invest. 68 : 22-28, February, 2021
Keywords : depression, adolescence, vulnerability, intervention
INTRODUCTION
 
Depression is a syndrome composed of multiple symptoms, 
such as depressed mood and loss of interest, and depression in 
childhood and adolescence is diagnosed from clinical symptoms 
using the same diagnostic criteria as adult depression (1). The 
prevalence of depression in childhood is 1-2% with no gender 
difference, and it increases sharply in adolescence. A recent 
epidemiological study reported the 12-month prevalence of de-
pressive disorder in adolescents to be 8.2%, being approximately 
two-fold higher in girls than in boys (2). The onset of depression 
peaks between the ages of 15 and 18, with the highest gender 
ratio (3). Adolescent onset depression is more heritable than 
preadolescent onset depression, and more chronic and recurrent 
than adult onset depression (4). In addition, there are important 
differences between adolescent and adult depression in terms 
of treatment response. Rapid biological and social development 
during adolescence is hypothesized to induce depression in those 
who are vulnerable. This review describes the updated etiology 
and clinical features, and focuses on appropriate therapeutic in-
terventions for adolescent depression. In this article, depression 
is synonymous with major depressive disorder (MDD). 
VULNERABILITY TO DEPRESSION AMONG 
ADOLESCENTS
Heredity
Family studies and twin studies revealed that offspring with 
depressed parents had a two- to four-fold increase in the risk 
of depression (5-7). However, the proportion of genetic factors 
in the development of depression is 30~40%, lower than that 
of schizophrenia and bipolar disorder (8). Depression is caused 
by the interaction of genetic and environmental factors. Sero-
tonin-transporter-linked polymorphic region (5-HTTLPR) is 
the most frequently reported candidate gene associated with 
early-onset depression. Individuals with the short 5-HTTLPR 
variant exhibited more diagnosable depression in relation to a 
history of child abuse and later stressful life event, whereas indi-
viduals without the short 5-HTTLPR variant had no change in 
the risk of developing depression despite having similar experi-
ences (9, 10). These studies emphasized the effects of 5-HTTLPR 
and stress interaction (GxE interaction) on the development of 
depression. There are also many reports of a positive association 
between methylation of brain-derived neurotropic factor (BDNF) 
gene, one of the epigenetic decorations on the genome caused by 
environmental factors, and adolescent depression (11). 
Environmental risk factors
Child maltreatment and family adversity
 Childhood abuse and family dysfunction increased the risk of 
developing depression in children, and experiences of abuse and 
family dysfunction in adolescence also increased the risk of de-
veloping depression (12). In addition, childhood abuse increased 
the onset of depression from adolescence to adulthood, earlier 
than controls, and most first-time episodes appeared between 
the ages of 12 and 15 (13, 14).
A study that investigated the relationship between family-fo-
cused adverse experiences from early childhood to adolescence 
and adolescent mental health reported that both the moder-
ate adversity group (family loss / discord, economic difficulties, 
maternal mental illness, and father’s atypical parenting) and 
severe adversity group (including child abuse) increased the risk 
of developing disruptive behavior disorders and depression, re-
spectively, compared with the low adversity group. In the severe 
adversity group, the odds rate was associated with an 8.0-fold 
increase in disruptive behavior disorders and 4.8-fold increase 
in depression (15).
Peer victimization
Peer victimization in childhood increased the risk of develop-
ing depression and anxiety in early adolescence, and depressive 
symptoms were more likely to be prolonged (16). The experience 
of bullying in childhood also increased the risk of developing 
depression and suicidality even in mid-adolescence (17). In both 
studies, individuals victimized by peers had a greater risk of 
reporting depression even after adjustment for family adversity, 
and more serious bullying had a greater impact.
Pubertal endocrine alterations
Exposure to sex hormones in the brain during puberty 
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activates the development and coordination of the prefrontal 
cortex, amygdala, and hypothalamus. Hormonal and physical 
changes accompanying puberty may be associated with an 
increased risk of depression in puberty ; however, the mecha-
nism is unknown. A linear relationship between estrogen levels 
and depressive symptoms in pre- and post-pubertal girls was 
previously reported, and a weak association between estrogen 
levels and negative affect was identified (14, 18). Furthermore, 
increased levels of oxytocin may increase the desire for interper-
sonal connection among adolescent girls, which is likely to cause 
hypersensitivity to interpersonal breakups and conflict, thereby 
increasing their vulnerably to developing depression (18-20).
NEUROBIOLOGY
Neurotransmission and endocrinology
Serotonin and dopamine systems
The serotonin (5-HT) system starts developing before birth 
and matures in early childhood. As serotonin regulates neu-
roplasticity, dysfunction of 5-HT system and serotonergic neu-
roplasticity, especially during early life, may be related to the 
pathophysiology of depression (21). On the other hand, the do-
pamine system matures during adolescence. Exposure to stress 
during this period can affect maturation of the frontal cortex, 
inducing impulse dysregulation and neuropsychiatric disorders 
(22).
Hypothalamus–pituitary–adrenal axis
Hypercortisolemia and non-suppression on the dexametha-
sone suppression test (DST) are noted in depressed adults (23, 
24). The hypothalamus–pituitary–adrenal (HPA) axis, the 
major stress system in the body, is a neuroendocrine system in-
volved in the production of the stress hormone cortisol by the ad-
renal glands. However, neurotoxicity and neuroinflammation by 
excessive exposure of the hippocampus to glucocorticoids cause 
glucocorticoid-induced changes in synaptic plasticity, reduction 
in neurogenesis, and in some cases, neuronal atrophy and cell 
death. Prenatal and childhood adversity can lead to a decreased 
hippocampal volume and long-term dysregulation of the HPA 
axis, resulting in diminished memory and learning abilities and 
increased risk of developing future depression (25-27). HPA-axis 
dysregulation, such as high baseline cortisol levels and atypical 
responses to DST, has also been observed in children and ado-
lescents with depression (28). Adolescents with depression who 
have higher cortisol levels required a longer time to recover from 
depressive episodes and were more likely to exhibit recurrence 
after stressful experiences (29).
Sleep
Insomnia has a bidirectional relationship with the onset 
and growth of depressive symptoms. In relation to circadian 
rhythms, adolescent depression predicted the eveningness chro-
notype, whereas the eveningness chronotype predicted depres-
sive symptoms and the onset of depression, which suggests an 




Positive affectivity / affect (PA) increases gradually in children 
of normal control parents. In contrast to the normative increase 
in PA, negative affectivity / affect (NA) displays generally de-
crease from infancy up to around late childhood. However, 
in a longitudinal study of offspring with and without a high 
familial risk for depression from 1 to 9 years of age, there was 
no difference in NA, but PA was consistently low in high-risk 
children (31). In a study of face processing in children and 
adolescents at high risk and low risk using fMRI, high-risk 
subjects exhibited higher activity in the amygdala and nucleus 
accumbens (a part of the striatum) for scary facial expressions, 
and lower activity for happy facial expressions (32). A study that 
examined attentional bias to emotional faces (sad, angry, and 
happy compared with neutral) found that depressed adolescents 
demonstrated a selective attention bias towards sad faces com-
pared with controls among past and current MDD patients. In 
addition, adolescents with both depression and anxiety had an 
attention bias to both sad and angry faces, with boys avoiding 
happy faces (33). In an affective go / no go task, only adolescents 
with current MDD responded more quickly to negative (sad) 
words, had delayed responses to positive (happy) words, and had 
a selective attention bias to negative words and poor attention 
switching compared with healthy subjects and MDD patients in 
remission (34).
Low PA and attention to negative emotional stimuli in chil-
dren and adolescents at high risk of depression are considered to 
be the core factors for developing depression (35).
Reward processing and decision making
The approach system is related to reward behaviors and is 
largely controlled by the ventral striatum. The avoidance sys-
tem is related to avoidance behaviors and is mostly controlled 
by the amygdala. The ability of cognitive control to suppress 
inappropriate behaviors in favor of goal-oriented ones generally 
increases linearly from childhood to adolescence. Adolescents 
exhibit similar activity in the ventral striatum to adults, but 
the activity in their prefrontal regions is more similar to that in 
children. Thus, during adolescence relative to childhood or adult-
hood, immature prefrontal region engagement may not provide 
sufficient top-down control via the activated ventral striatum, 
which may explain why adolescents are more likely to engage 
in risky or reward-dependent behaviors compared with children 
and adults (36). The development of both reward function and ex-
ecutive function is likely based on changes in dopamine function 
(37). However, in situations where emotive cues are not present, 
cortical control systems are not impaired, leading adolescents to 
more optimal behaviors (36). Therefore, in adolescents, adaptive 
and goal-oriented behaviors require the maturation of systems 
to process emotional stimuli, reward functions, and cognitive 
control.
Adolescence may be the developmental period during which 
reward function in depression is most markedly disrupted. Ado-
lescents with depression exhibit reduced reactivity in the stria-
tum in response to decision making, anticipation, and outcomes 
involving monetary rewards. However, the medial prefrontal 
cortex (mFC) responses were not consistent with higher or lower 
outcomes (38). Interventions related to mindfulness can reduce 
mFC over-regulation if the reward function is impaired through 
over-regulation of the mFC striatum. If the reward function is 
impaired due to an initially low striatum reaction to the reward, 




Warm supportive relationships, more adaptive emotional 
regulation skills, and an adaptive coping style for stress can 
protect at-risk adolescents from developing depression (39-42). 
Among resilient adolescent girls, individuals with a familial risk 
of depression who did not develop depression had greater con-
nectivity between the amygdala and orbitofrontal cortex than 
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high-risk individuals who developed depression. In the resilient 
girls group only, the strength of amygdala-orbitofrontal cortex 
connectivity was correlated with positive life events. Resilient 
adolescent females had compensatory functional connectivity 
patterns in emotional regulatory networks that correlated with 
positive life events, suggesting that experience-dependent plas-
ticity within these networks confers resilience to depression (41). 
Adolescents with a history of childhood maltreatment who were 
better able to regulate emotions through regulating amygdala 




The clinical symptoms of MDD in children and adolescents 
have similarities with those in adults, but there are several dif-
ferences that can be attributed to the physical, emotional, cogni-
tive, and social developmental stages of children and adolescents. 
DSM-5 criteria describe in the note that depressed mood can be 
irritable mood in children and adolescents, and that body weight 
loss consider failure to make expected weight gain in children.  
In both children and adolescents, vegetative symptoms (appe-
tite and weight change, insomnia, and fatigue) are common and 
physical complaints, such as headaches and abdominal pain, are 
more likely to be observed in children and adolescents than in 
adults (43, 44). A previous meta-analysis reported that the base-
line rates of suicide-related symptoms (suicidal thoughts and 
behaviors) in adolescents, adults, and geriatric patients enrolled 
in randomized controlled trials (RCT) of pharmacotherapy for 
depression were 20%, 5%, and 3%, respectively (45).
Cole et al. conducted a large multi-site trial to evaluate more 
reliable data about depression severity than conventional symp-
tom counts in 5- to 18-year-old child and adolescent depression 
by using item response theory (IRT). According to their study, 
concentration problems, worthlessness / guilt, and sleep dis-
turbance were noted at mild depression, whereas psychomotor 
agitation / retardation, appetite / weight disturbance, and suicidal 
ideation / attempts were noted at severer levels of depression (46).
Comparing the symptoms that pediatric and adolescent de-
pression patients had in common, anhedonia, weight change, 
hypersomnia, serious suicide attempts, and use of alcohol and 
illicit drugs were more common in adolescents. There were no 
sex differences other than female adolescents having greater 
suicidality (47, 48).
Thus, in adolescent depression, depressed mood, irritability, 
and anhedonia are the core symptoms, followed by physical 
symptoms of appetite and weight change, insomnia, and hy-
persomnia, with suicidal ideation and attempts more likely 
observed in severe cases.
Bipolar depression
Diagnosis of Bipolar disorder (BP) requires the presence of at 
least one past manic or hypomanic episode, but the first episode 
of BP in youth is usually a depressive episode. The risk of BP in 
prepubertal depression is estimated to be 10-20% (49). It takes 
an average of 10 years to correctly identify and begin the treat-
ment of BP, therefore more useful index for differential diagnosis 
in clinical symptoms between unipolar and bipolar depression is 
needed. Clinical features that predict bipolar depression include 
family history of bipolar disorder, as well as depression with psy-
chotic features, hypomania associated with antidepressant use, 
depression with mixed features and with subsyndromal manic 
symptoms, particularly motor hyperactivity, distractibility, and 
pressured speech (49-52).
Prodromal symptoms
Insomnia is a well-known precursor to depression in adults, 
and even in children, a twin study reported that insomnia at age 
8 predicted depression at age 10 (53). Subthreshold depressive 
symptoms increase the risk of MDD after one year (54, 55). Anx-
iety symptoms often precede depression, but twin studies also 
suggested genetic effects (56, 57).
Comorbidity
Adolescents with depression often have other psychiatric 
disorders (6, 58). Anxiety disorders are most often comorbid 
with depression or precede depression (59-61). Attention-defi-
cit / hyperactivity disorder (ADHD), oppositional defiant disorder 
(ODD), and substance abuse are also common comorbidities. In 
particular, ADHD is more common with pediatric depression 
and substance abuse is more common with adolescent depression 
(48).
TREATMENTS FOR ADOLESCENT DEPRESSION
Treatment of depression is divided into three phases : acute 
treatment for 2-3 months, consolidation therapy for 3-6 months, 
and maintenance therapy for 12 months or longer. For all pa-
tients, consolidation therapy is required to prevent recurrence, 
and maintenance therapy is performed for more severe, re-
current, and chronic patients. Each phase of treatment should 
include psychoeducation, supportive psychotherapy or manage-
ment, family involvement, and school involvement. In uncom-
plicated or briefly depressed adolescents, or those with mild 
psychosocial impairment, these basic interventions alone can 
have therapeutic effects. In adolescents with moderate to severe 
depression, chronic and recurrent depression, or suicidality, 
interventions using more specific types of treatments, such as 
cognitive behavioral therapy (CBT), interpersonal therapy 
(IPT), pharmacotherapy, or a combination of pharmacotherapy 
and psychotherapy, are required. Adolescents with moderate 
depression can only be treated by CBT or IPT, but more severe 
depression generally requires medication (62).
CBT
CBT focuses on identifying cognitive distortions that may 
lead to depressive mood using problem-solving techniques and 
behavioral activation methods, and emotional regulation skills 
and other skills to control and overcome depression. There is 
weaker evidence for CBT (and IPT) in the treatment of children 
with depression even though it is a well-established intervention 
for adolescents with depression (63, 64). The Treatment of Ado-
lescent Depression Study (TADS) was a large multi-center RCT 
that examined the effectiveness of standard treatment options 
for MDD in adolescents, and compared the therapeutic effects in 
four groups : CBT-only, fluoxetine only, CBT and fluoxetine, and 
placebo group. Although CBT-only treatment was not more effec-
tive than placebo, the combination of CBT and pharmacotherapy 
(fluoxetine) in the treatment of adolescents with moderate to 
severe depression was the most effective (65, 66). However, CBT 
is less effective in adolescents with a history of abuse or trauma, 
current parental depression, or low income (63). In the analy-
sis of Treatment of SSRI-Resistant Depression in Adolescents 
(TORDIA), combined treatment with CBT and antidepressants 
was more advantageous for adolescents whose depression was 
more severe (67). Providing personalized treatment components 
for adolescents with multiple problems, such as behavioral prob-
lems, in addition to depression and interventions integrated with 
trauma-focused CBT is useful for abused depressed adolescents 
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(68, 69).
IPT
IPT conceptualizes depression in relation to loss, role conflict, 
and inconsistencies in personal relationships. Therefore, IPT 
aims to help individuals with depression reduce their personal 
conflicts by teaching problem-solving skills in human relation-
ships, and helping to correct dysfunctional communication and 
relationship patterns. IPT was demonstrated to be superior to 
supportive management twice a month, with the most marked 
difference in late adolescents with moderate or severe depression 
(70). IPT was as effective as CBT against adolescent depression 
(71).
Pharmacotherapy
Tricyclic antidepressants, which are effective for adult depres-
sion, are not effective for childhood depression and less effective 
for adolescent depression (72). Adolescents receiving a serotonin 
re-uptake inhibitor (SSRI) had a good response rate of approx-
imately 60%, but the response rate was 35% to 60% for placebo 
(65, 73-75). These small or no differences between the SSRI and 
placebo were considered to be in part because depressive symp-
toms in youth can respond better to supportive management, 
and that these studies included subjects with mild to moderate 
depression or those with low antidepressant doses and other 
methodological problems (62, 75). Studies that enrolled more 
severe participants had lower placebo response rates, and re-
ported significant differences between drugs and placebos (76). 
Antidepressants demonstrated to be effective compared with 
placebo were fluoxetine, sertraline, citalopram / escitalopram, 
and venlafaxine, but their effects on depression and anxiety were 
higher in adolescents than in children, and only fluoxetine was 
effective for childhood depression in patients under 12 years of 
age compared with placebo (77).
 A meta-analysis of 24 previous RCT of 9 different antide-
pressants by the FDA reported that antidepressants slightly 
increased suicidal ideation, which led to placement of the ‘Black 
Box Warning’ on all classes of antidepressants in children and 
adolescents. However, in a subsequent thorough meta-analysis, 
the overall number needed to harm (NNT to observe one ad-
verse event caused by active treatment) for MDD was 112. The 
overall NNT of antidepressants for childhood depression is 10. 
Therefore, considering the limitations of meta-analyses, nearly 
11-times more depressed patients may respond favorably to 
antidepressants than spontaneously report suicidality (62, 77).
However, suicide ideation and behaviors in adolescent depres-
sion were reported to decrease with the improvement of depres-
sive symptoms by antidepressants, as in adults and geriatric 
patients, but the significant reduction in suicidal thoughts and 
behaviors due to antidepressants observed in adults and geri-
atric patients was not observed in adolescents (45). Therapeutic 
options other than medication are thus required, especially for 
suicidal ideation and behaviors in children and adolescents.
PREVENTION
CBT- and IPT-based interventions as prevention programs 
have been developed as preventive interventions for children and 
adolescents with depression. The purpose of these preventive in-
terventions is to prevent depression or delay the onset of clinical-
ly significant symptoms. Implementing preventive programs for 
children when their behavior is more amenable is more likely to 
produce better outcomes than if treatment is administered after 
rigid patterns of cognition and behavior have been established 
(78). A systematic review of school-based prevention programs 
for children aged 5 to 19 reported small preventive effects (effect 
sizes d = 0.12 to 0.23) against depression after intervention and 
follow-up at 6 and 12 months. In the subgroup analysis, targeted 
populations were more effective than universal populations, and 
programs for children were more effective than programs for late 
adolescents (78). Based on Cochrane’s review of meta-analyses in 
clinical and community-settings, and school-based trials, the tri-
als were effective for depressive symptoms up to 12 months, had 
no long-term effects, and were significantly more effective at tar-
geted prevention (79). A RCT of a cognitive-behavioral preven-
tion program for high-risk adolescents with parental depression 
reduced the rate of depression after 6 years (80). Kovacs noted 
that preventive trials for youth MDD may benefit from a com-
bined approach of new or different interventions based on case 
selection that combines multiple indicators of vulnerability (35).
CONCLUSIONS
In therapeutic interventions for adolescent depression, it is im-
portant to consider the biological and environmental vulnerabil-
ities of individuals, and to assess their emotional, cognitive, and 
behavioral characteristics. Evaluating the severity of depression 
and comorbid symptoms is also required to optimize treatment. 
A targeted approach in early childhood may be effective at pre-
venting the development of depression.
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